The Stanford Cancer Center brings together physicians with exceptional expertise in treating liver cancer. Patients with hepatocellular carcinoma (HCC) or liver tumors (including cancer that has spread to the liver) are evaluated and treated by the multidisciplinary physicians of the Liver Tumor Clinic and tumor board.
The tumor board team includes specialists to address both the treatment of the tumor and any underlying liver disease such as hepatitis B.
The team includes:
- Liver surgeon
- Liver transplant surgeon
- Hepatologists
- Interventional and diagnostic radiologists
- Medical and radiation oncologists
- Pathologists
- Molecular biologists studying the genomics of HCC
Although the treatment approach is constantly evolving, our goals are to eradicate the tumor without subjecting the patient to an undue risk of hepatic failure, and to prolong survival as well as quality of life.
In addition, physicians at the Liver Tumor Clinic are internationally recognized for their groundbreaking work on liver cancer in the Asian population. Liver cancer occurs more frequently in Asians than in people of other ethnicity because hepatitis B infection is more common in Asians and increases the risk of developing liver cancer.
The Asian Liver Center at Stanford University maintains its own comprehensive Web site describing physicians' expertise, and makes this information available in English, Chinese (traditional and simplified), Korean, and Vietnamese.